Quick answer
Repligen Corp (RGEN) reported revenue of $738.3M and net income of $48.9M for the fiscal year ended 2025-12-31, up 16.4% from $634.4M the year before, per its 10-K filed with the SEC on 2026-02-26. Long-term debt stood at $542.2M.
Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-12-31) | $738.3M | $48.9M | $542.2M |
| 2024 (FY ending 2024-12-31) | $634.4M | -$25.5M | $525.6M |
| 2023 (FY ending 2023-12-31) | $632.4M | $35.6M | โ |
| 2022 (FY ending 2022-12-31) | $801.5M | $186.0M | โ |
| 2021 (FY ending 2021-12-31) | $670.5M | $128.3M | โ |
| 2020 (FY ending 2020-12-31) | $366.3M | $59.9M | โ |
| 2019 (FY ending 2019-12-31) | $270.2M | $21.4M | โ |
| 2018 (FY ending 2018-12-31) | $194.0M | $16.6M | โ |
| 2017 (FY ending 2017-12-31) | $141.2M | $28.4M | โ |
| 2016 (FY ending 2016-12-31) | $104.5M | $11.7M | โ |
Frequently asked questions
What is Repligen Corp's annual revenue?
Repligen Corp (RGEN) reported revenue of $738.3M and net income of $48.9M for the fiscal year ended 2025-12-31, up 16.4% from $634.4M the year before, per its 10-K filed with the SEC on 2026-02-26. Long-term debt stood at $542.2M.
What is RGEN's profit margin?
Repligen Corp's net margin was 6.6% in the fiscal year ended 2025-12-31.
Related
- REGN revenue, net income and debt history (Regeneron Pharmaceuticals, Inc.)
- REXR revenue, net income and debt history (Rexford Industrial Realty, Inc.)
- RGA revenue, net income and debt history (Reinsurance Group Of America, Incorporated)
- RGLD revenue, net income and debt history (Royal Gold, Inc)
- RHP revenue, net income and debt history (Ryman Hospitality Properties, Inc.)
- RIVN revenue, net income and debt history (Rivian Automotive, Inc. / DE)
- RJF revenue, net income and debt history (Raymond James Financial, Inc.)
- RKLB revenue, net income and debt history (Rocket Lab Corp)
Last updated Oct 16, 2026, 10:42 PM ET. Data only, not financial or tax advice.